121 related articles for article (PubMed ID: 34955352)
1. Therapeutic efficacy of intra-arterial docetaxel and nedaplatin infusion concomitant with radiotherapy for T4 maxillary sinus squamous cell carcinoma.
Heianna J; Makino W; Hirakawa H; Yamashita Y; Tomita H; Murayama S
Int J Oral Maxillofac Surg; 2022 Sep; 51(9):1123-1130. PubMed ID: 34955352
[TBL] [Abstract][Full Text] [Related]
2. Clinical T staging is superior to fluorodeoxyglucose positron emission tomography for predicting local outcomes after intra-arterial infusion chemoradiotherapy for maxillary sinus squamous cell carcinoma.
Doi H; Fujiwara M; Kitajima K; Tanooka M; Terada T; Noguchi K; Ishikura R; Kamikonya N; Yamakado K
Nagoya J Med Sci; 2018 Nov; 80(4):541-550. PubMed ID: 30587868
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic efficacy of selective intra-arterial chemoradiotherapy with docetaxel and nedaplatin for fixed bulky nodal disease in head and neck cancer of unknown primary.
Heianna J; Makino W; Hirakawa H; Agena S; Tomita H; Ariga T; Ishikawa K; Takehara S; Maemoto H; Murayama S
Eur Arch Otorhinolaryngol; 2022 Jun; 279(6):3105-3113. PubMed ID: 34628548
[TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant Superselective Intra-Arterial Cisplatin Chemoradiotherapy Combined With Surgery in Patients With T4 Squamous Cell Carcinoma of the Maxillary Sinus.
Ikeda M; Suzuki M; Matsuzuka T; Ishii S; Sato H; Murono S
J Oral Maxillofac Surg; 2022 Aug; 80(8):1445-1450. PubMed ID: 35636468
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic efficacy of selective intraarterial chemoradiotherapy with docetaxel and nedaplatin for human papilloma virus-negative oropharyngeal cancer.
Heianna J; Makino W; Hirakawa H; Agena S; Tomita H; Ariga T; Ishikawa K; Takehara S; Kusada T; Maemoto H; Maeda H; Murayama S
Auris Nasus Larynx; 2022 Jun; 49(3):468-476. PubMed ID: 34763986
[TBL] [Abstract][Full Text] [Related]
6. Management for squamous cell carcinoma of the nasal cavity and ethmoid sinus: A single institution experience.
Homma A; Nakamaru Y; Sakashita T; Onimaru R; Terasaka S; Tsuchiya K; Yoshida D; Yasuda K; Hatakeyama H; Furusawa J; Mizumachi T; Kano S; Shirato H; Fukuda S
Auris Nasus Larynx; 2015 Oct; 42(5):377-81. PubMed ID: 25748513
[TBL] [Abstract][Full Text] [Related]
7. Organ preservation with daily concurrent chemoradiotherapy using superselective intra-arterial infusion via a superficial temporal artery for T3 and T4 head and neck cancer.
Mitsudo K; Shigetomi T; Fujimoto Y; Nishiguchi H; Yamamoto N; Furue H; Ueda M; Itoh Y; Fuwa N; Tohnai I
Int J Radiat Oncol Biol Phys; 2011 Apr; 79(5):1428-35. PubMed ID: 20605340
[TBL] [Abstract][Full Text] [Related]
8. Radiotherapy in late elderly (aged 75 or older) patients with paranasal sinus carcinoma: a single institution experience.
Doi H; Kitajima K; Tanooka M; Terada T; Noguchi K; Takada Y; Fujiwara M; Ishikura R; Kamikonya N; Hirota S
Eur Arch Otorhinolaryngol; 2016 Dec; 273(12):4485-4492. PubMed ID: 27314860
[TBL] [Abstract][Full Text] [Related]
9. Superselective intra-arterial cisplatin infusion and concomitant radiotherapy for maxillary sinus cancer.
Homma A; Sakashita T; Yoshida D; Onimaru R; Tsuchiya K; Suzuki F; Yasuda K; Hatakeyama H; Furusawa J; Mizumachi T; Kano S; Inamura N; Taki S; Shirato H; Fukuda S
Br J Cancer; 2013 Dec; 109(12):2980-6. PubMed ID: 24196792
[TBL] [Abstract][Full Text] [Related]
10. Preliminary results of proton beam therapy combined with weekly cisplatin intra-arterial infusion via a superficial temporal artery for treatment of maxillary sinus carcinoma.
Nakamura T; Azami Y; Ono T; Yamaguchi H; Hayashi Y; Suzuki M; Hatayama Y; Tsukiyama I; Hareyama M; Kikuchi Y; Takayama K; Fuwa N
Jpn J Clin Oncol; 2016 Jan; 46(1):46-50. PubMed ID: 26538461
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors and treatment outcomes of advanced maxillary gingival squamous cell carcinoma treated by intra-arterial infusion chemotherapy concurrent with radiotherapy.
Hayashi Y; Osawa K; Nakakaji R; Minamiyama S; Ohashi N; Ohya T; Iida M; Iwai T; Ozawa T; Oguri S; Koizumi T; Hirota M; Kioi M; Hata M; Mitsudo K
Head Neck; 2019 Jun; 41(6):1777-1784. PubMed ID: 30694002
[TBL] [Abstract][Full Text] [Related]
12. The superselective intra-arterial infusion of cisplatin and concomitant radiotherapy (RADPLAT) is effective for metastatic lymph nodes in head and neck squamous cell carcinoma.
Kano S; Suzuki T; Yoshida D; Tsushima N; Hamada S; Yasuda K; Uchinami Y; Aoyama H; Homma A
Int J Clin Oncol; 2023 Sep; 28(9):1121-1128. PubMed ID: 37289379
[TBL] [Abstract][Full Text] [Related]
13. Radiation with concomitant superselective intra-arterial cisplatin infusion for maxillary sinus squamous cell carcinoma.
Ebara T; Ando K; Eishima J; Suzuki M; Kawakami T; Horikoshi H; Tamaki Y
Jpn J Radiol; 2019 Jun; 37(6):494-499. PubMed ID: 30915648
[TBL] [Abstract][Full Text] [Related]
14. [Maxillary Cancer with Metastasis to the Rouviere Nodes -- Complete Response to Chemoradiotherapy Using a Selective Intra-Arterial Infusion Technique].
Yamashiro K; Heianna J; Azama K; Iraha Y; Yamashiro T; Kinoshita R; Toita T; Toyama M; Agena S; Maeda H; Suzuki M; Murayama S
Gan To Kagaku Ryoho; 2016 Feb; 43(2):243-6. PubMed ID: 27067691
[TBL] [Abstract][Full Text] [Related]
15. Intra-arterial cisplatin and concomitant radiation therapy followed by surgery for advanced paranasal sinus cancer.
Samant S; Robbins KT; Vang M; Wan J; Robertson J
Arch Otolaryngol Head Neck Surg; 2004 Aug; 130(8):948-55. PubMed ID: 15313865
[TBL] [Abstract][Full Text] [Related]
16. Nedaplatin plus docetaxel versus cisplatin plus docetaxel for advanced or relapsed squamous cell carcinoma of the lung (WJOG5208L): a randomised, open-label, phase 3 trial.
Shukuya T; Yamanaka T; Seto T; Daga H; Goto K; Saka H; Sugawara S; Takahashi T; Yokota S; Kaneda H; Kawaguchi T; Nagase S; Oguri T; Iwamoto Y; Nishimura T; Hattori Y; Nakagawa K; Nakanishi Y; Yamamoto N;
Lancet Oncol; 2015 Dec; 16(16):1630-8. PubMed ID: 26522337
[TBL] [Abstract][Full Text] [Related]
17. Dose-Finding and Efficacy Confirmation Trial of the Superselective Intra-arterial Infusion of Cisplatin and Concomitant Radiation Therapy for Locally Advanced Maxillary Sinus Cancer (JCOG1212): Results of the Efficacy Confirmation Phase in Patients with T4aN0M0.
Homma A; Mikami M; Matsuura K; Onimaru R; Yoshida D; Shinomiya H; Ohkoshi A; Hayashi R; Saito Y; Tachibana H; Shiga K; Ueda T; Uemura H; Nakamura K; Fukuda H;
Int J Radiat Oncol Biol Phys; 2024 Apr; 118(5):1271-1281. PubMed ID: 38008195
[TBL] [Abstract][Full Text] [Related]
18. The incidence of late neck recurrence in N0 maxillary sinus squamous cell carcinomas after superselective intra-arterial chemoradiotherapy without prophylactic neck irradiation.
Sakashita T; Homma A; Hatakeyama H; Kano S; Mizumachi T; Furusawa J; Yoshida D; Fujima N; Onimaru R; Tsuchiya K; Yasuda K; Shirato H; Fukuda S
Eur Arch Otorhinolaryngol; 2014 Oct; 271(10):2767-70. PubMed ID: 24213278
[TBL] [Abstract][Full Text] [Related]
19. Salvage operations for patients with persistent or recurrent cancer of the maxillary sinus after superselective intra-arterial infusion of cisplatin with concurrent radiotherapy.
Sakashita T; Homma A; Hatakeyama H; Kano S; Mizumachi T; Furusawa J; Yoshida D; Fujima N; Onimaru R; Tsuchiya K; Yasuda K; Shirato H; Suzuki F; Fukuda S
Br J Oral Maxillofac Surg; 2014 Apr; 52(4):323-8. PubMed ID: 24582012
[TBL] [Abstract][Full Text] [Related]
20. The efficacy and safety of concurrent chemoradiotherapy for maxillary sinus squamous cell carcinoma patients.
Nishimura G; Tsukuda M; Mikami Y; Matsuda H; Horiuchi C; Satake K; Taguchi T; Takahashi M; Kawakami M; Hanamura H; Watanabe M; Utsumi A
Auris Nasus Larynx; 2009 Oct; 36(5):547-54. PubMed ID: 19097833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
